Creightons Director’s Matched Share Deal Leaves Stake Unchanged

The latest announcement is out from Creightons ( (GB:CRL) ).

Creightons plc reported that non-executive director and PDMR Paul Watts carried out a matched sale and repurchase of 160,000 ordinary shares in the company over two days on AIM. The transactions, executed at prices between 22.8p and 24.0p per share, leave his total shareholding unchanged at 160,000 shares, indicating no net change in his economic interest in the group.

The disclosure, made under the UK Market Abuse Regulation, provides transparency around board-level dealing in Creightons’ stock without altering the overall insider ownership structure. Investors are likely to view the activity as administrative or portfolio-related rather than a directional bet on the company’s prospects, given the unchanged final position.

The most recent analyst rating on (GB:CRL) stock is a Hold with a £25.00 price target. To see the full list of analyst forecasts on Creightons stock, see the GB:CRL Stock Forecast page.

Spark’s Take on CRL Stock

According to Spark, TipRanks’ AI Analyst, CRL is a Outperform.

Creightons’ strong financial performance and attractive valuation are the primary drivers of its overall score. The robust balance sheet and low P/E ratio suggest financial stability and potential undervaluation. However, technical indicators show a bearish trend, and the decline in free cash flow growth is a risk that needs addressing.

To see Spark’s full report on CRL stock, click here.

More about Creightons

Creightons plc is a British-based beauty and well-being brand owner and manufacturer. The group develops and produces personal care and cosmetic products, operating primarily in the U.K. market and supplying both its own brands and private-label lines to retail and other distribution channels.

Average Trading Volume: 118,551

Technical Sentiment Signal: Sell

Current Market Cap: £15.9M

For detailed information about CRL stock, go to TipRanks’ Stock Analysis page.